
The Sterile Injectables CDMO Market was valued at USD 3.89 billion in 2023 and is projected to expand significantly, reaching USD 8.82 billion by 2032. This growth is underpinned by an impressive compound annual growth rate (CAGR) of 9.54% over the forecast period 2024-2032. The market’s rapid expansion reflects the pharmaceutical industry's escalating need for high-quality, efficient contract d..